Clinical Trials
41 trialsSKYSCRAPER-06
Hoffmann-La Roche
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer
NRG Oncology
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
SWOG Cancer Research Network
Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
BM
Alpha Biopharma (Jiangsu) Co., Ltd.
D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC
Betta Pharmaceuticals Co., Ltd.
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Canadian Cancer Trials Group
SUPER BRAIN
Sun Yat-sen University
DENIM
Amphera BV
ATOMIC
Polaris Group
Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer
Canadian Cancer Trials Group
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
National Cancer Institute, Naples
MAPS
Intergroupe Francophone de Cancerologie Thoracique
MK-3475-010
Merck Sharp & Dohme LLC
CATIQ
Dana-Farber Cancer Institute
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
United Therapeutics
Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer
Canadian Cancer Trials Group
CIK
Tianjin Medical University Cancer Institute and Hospital
Adjuvant Pazopanib in Stage I NSCLC
Intergroupe Francophone de Cancerologie Thoracique
Bioinformation Therapy for Lung Cancer
Fuda Cancer Hospital, Guangzhou
Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects
Dong-A University Hospital
ALTER0303
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
TASTE
Intergroupe Francophone de Cancerologie Thoracique
INSTEP
AstraZeneca
CPC
Intergroupe Francophone de Cancerologie Thoracique
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
AHS Cancer Control Alberta
Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC
Fudan University
Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?
The Miriam Hospital
A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy
PIMERIndia
Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer
Transgene
Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC
Sun Yat-sen University
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
Memorial Sloan Kettering Cancer Center
Evaluation of the Bio-Seal Biopsy Track Plug
M.D. Anderson Cancer Center
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis
Pierian Biosciences
Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer
ChineseAMS
Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
Hamamatsu University
Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer
Hadassah Medical Organization
SESAME
Sanofi
A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)
University of British Columbia